Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date27 Dec 2019 |
100 Clinical Results associated with Hunan 999 Nankai Pharmacy Co., Ltd.
0 Patents (Medical) associated with Hunan 999 Nankai Pharmacy Co., Ltd.
100 Deals associated with Hunan 999 Nankai Pharmacy Co., Ltd.
100 Translational Medicine associated with Hunan 999 Nankai Pharmacy Co., Ltd.